Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 20/20 | 0.84 |
| ▸ | PGR | P06401 | 7/20 | 0.84 |
| ▸ | NR3C2 | P08235 | 4/20 | 0.84 |
| ▸ | AR | P10275 | 3/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6554294 | 0.94 | NR3C1 (0.76) | NR3C1PGRNR3C2AR | |
| SCHEMBL6554366 | 0.91 | NR3C1 (1.00) | NR3C1PGRNR3C2AR | |
| SCHEMBL6584227 | 0.89 | NR3C1 (0.85) | NR3C1PGRNR3C2AR | |
| SCHEMBL6076313 | 0.89 | NR3C1 (0.83) | NR3C1PGRNR3C2AR | |
| SCHEMBL5643374 | 0.88 | NR3C1 (0.77) | NR3C1PGRNR3C2AR | |
| SCHEMBL5642683 | 0.87 | NR3C1 (0.69) | NR3C1PGRNR3C2AR | |
| SCHEMBL5643393 | 0.85 | NR3C1 (0.81) | NR3C1PGRNR3C2AR | |
| SCHEMBL5644171 | 0.85 | NR3C1 (0.77) | NR3C1PGRNR3C2AR | |
| SCHEMBL5643909 | 0.84 | NR3C1 (0.72) | NR3C1PGRNR3C2AR | |
| SCHEMBL5643233 | 0.83 | NR3C1 (0.83) | NR3C1PGRNR3C2AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7112584-B2 | Nonsteroidal antiinflammatory agents | SCHERING AG (DE) | 2006-09-26 | — | — | US | disclosed |
| EP-1572671-A1 | NON-STEROIDAL ANTI-INFLAMMATORY AGENTS | Schering Aktiengesellschaft (DE) | 2005-09-14 | — | — | EP | disclosed |
| US-20040209875-A1 | Nonsteroidal antiinflammatory agents | SCHERIN AKTIENGESELLSCHAFT (DE) | 2004-10-21 | — | — | US | disclosed |
| WO-2004058733-A1 | NON-STEROIDAL ANTI-INFLAMMATORY AGENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 2004-07-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040209875-A1 | Nonsteroidal antiinflammatory agents | PTGS1, PTGER1, PTGES | NR3C1 90/4885PGR 648/4885NR3C2 236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.